Skip to main content
. 2022 Sep 10;9:558. doi: 10.1038/s41597-022-01546-5

Fig. 2.

Fig. 2

Schematic illustration of experimental setup and data generation. (a) Animals were subjected to different STZ treatment regimens and the pancreata were collected over 3 weeks. The pancreata were subsequently divided into the three primary lobular compartments (splenic lobe (SL), duodenal lobe (DL) and gastric lobe (GL)) prior to whole mount immunohistochemistry (insulin-594 and GLUT2-680), agarose embedding and tissue clearing for OPT-scanning. dataset 1 consist of control, single high dose (SHD) and multiple low doses (MLD) at 1-, 2- and 3-weeks post STZ administration (n = 5, n = 3–5 and n = 3–5, respectively per time point). (b) Animals were subjected to a single high dose STZ treatment and recovered from hyperglycemia by transplanting islet of Langerhans to the anterior chamber of the eye (SHD + Tx). dataset 2 consists of data from pancreatic splenic lobe (SL) only from control samples (n = 7), SHD (n = 8) and SHD + Tx (n = 4) 4 weeks post STZ administration. (c) dataset 3 consists of LSFM image data and is generated based on a selection of representative samples from dataset 1.